Literature DB >> 25107626

Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.

M López1, M Palacio, A Goncé, S Hernàndez, F J Barranco, L García, M Loncà, J O Coll, E Gratacós, F Figueras.   

Abstract

The purpose of this investigation was to study the risk of intrauterine growth restriction in human immunodeficiency virus (HIV)-infected women and to describe the associated risk factors. A cohort study was performed among HIV-infected women who delivered in a single tertiary centre in Barcelona, Spain, from January 2006 to December 2011. Consecutive singleton pregnancies delivered beyond 22 weeks of pregnancy were included. Intrauterine growth restriction (IUGR) was defined as a birth weight below the 10th customised centile for gestational age and IUGR babies were compared to non-IUGR newborns. Intrauterine Doppler findings were described among IUGR foetuses. Baseline characteristics, HIV infection data and perinatal outcome were compared between groups. The results were adjusted for potential confounders. A total of 156 singleton pregnancies were included. IUGR occurred in 23.4 % of cases (38/156). In two-thirds of the cases detected before birth, Doppler abnormalities compatible with placental insufficiency were observed. IUGR pregnancies presented a worse perinatal outcome, mainly due to a higher risk of iatrogenic preterm delivery [adjusted odds ratio 6.9, 95 % confidence interval (CI) 1.4-33.5]. IUGR foetuses also had a higher risk of emergent Caesarean section and neonatal intensive care unit admission. No cases of intrauterine foetal death occurred. A high rate of IUGR was observed among HIV pregnancies, and it was associated with adverse perinatal outcomes, mainly iatrogenic preterm and very preterm birth due to placental insufficiency. Our results support that ultrasound detection and follow-up of IUGR foetuses should be part of routine antenatal care in this high-risk population to improve antenatal management.

Entities:  

Mesh:

Year:  2014        PMID: 25107626     DOI: 10.1007/s10096-014-2224-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  48 in total

1.  The association between HIV/AIDS during pregnancy and fetal growth parameters in Florida: a population based study.

Authors:  Hamisu M Salihu; Kara M Stanley; Euna M August; Hanna Weldeselasse; Alfred K Mbah; Valerie E Whiteman
Journal:  Curr HIV Res       Date:  2012-09       Impact factor: 1.581

Review 2.  Examination of the fetal cardiovascular system.

Authors:  Ahmet A Baschat
Journal:  Semin Fetal Neonatal Med       Date:  2011-02       Impact factor: 3.926

Review 3.  Placental pathology: a systematic approach with clinical correlations.

Authors:  R W Redline
Journal:  Placenta       Date:  2007-10-22       Impact factor: 3.481

4.  Factors influencing gestational age-adjusted birthweight in a national series of 600 newborns from mothers with HIV.

Authors:  Marco Floridia; Marina Ravizza; Anna Bucceri; Luisella Lazier; Alessandra Viganò; Salvatore Alberico; Giovanni Guaraldi; Gianfranco Anzidei; Brunella Guerra; Angela Citernesi; Matilde Sansone; Silvia Baroncelli; Enrica Tamburrini
Journal:  HIV Clin Trials       Date:  2008 Sep-Oct

5.  Value of a single early third trimester fetal biometry for the prediction of birth weight deviations in a low risk population.

Authors:  Paul A O M De Reu; L J M Smits; H P Oosterbaan; J G Nijhuis
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

6.  Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.

Authors:  A C Ross; T Leong; A Avery; M Castillo-Duran; H Bonilla; D Lebrecht; U A Walker; N Storer; D Labbato; A Khaitan; I Tomanova-Soltys; G A McComsey
Journal:  HIV Med       Date:  2011-11-21       Impact factor: 3.180

7.  Emergence of late-onset placental dysfunction: relationship to the change in uterine artery blood flow resistance between the first and third trimesters.

Authors:  Elisa Llurba; Ozhan Turan; Tania Kasdaglis; Chris R Harman; Ahmet A Baschat
Journal:  Am J Perinatol       Date:  2012-12-19       Impact factor: 1.862

8.  Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.

Authors:  Jennifer Y Chen; Heather J Ribaudo; Sajini Souda; Natasha Parekh; Anthony Ogwu; Shahin Lockman; Kathleen Powis; Scott Dryden-Peterson; Tracy Creek; William Jimbo; Tebogo Madidimalo; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Infect Dis       Date:  2012-10-12       Impact factor: 5.226

9.  Customized birthweight standards for a Spanish population.

Authors:  F Figueras; E Meler; A Iraola; E Eixarch; O Coll; J Figueras; A Francis; E Gratacos; J Gardosi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2007-02-06       Impact factor: 2.435

10.  High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.

Authors:  Roger L Shapiro; Sajini Souda; Natasha Parekh; Kelebogile Binda; Mukendi Kayembe; Shahin Lockman; Petr Svab; Orphinah Babitseng; Kathleen Powis; William Jimbo; Tracy Creek; Joseph Makhema; Max Essex; Drucilla J Roberts
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

View more
  5 in total

1.  Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy.

Authors:  Livo F Esemu; Emile K Yuosembom; Rui Fang; Shayne Rasay; Barriere A Y Fodjo; John T Nguasong; Winifrida Kidima; Gabriel L Ekali; John J Chen; Lishomwa Ndhlovu; Jude D Bigoga; Diane W Taylor; Rose G F Leke; Anna Babakhanyan
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

2.  Adverse perinatal outcomes associated with protease inhibitor-based antiretroviral therapy in pregnant women living with HIV: A systematic review and meta-analysis.

Authors:  Imogen Cowdell; Katharina Beck; Clara Portwood; Harriet Sexton; Mary Kumarendran; Zoe Brandon; Shona Kirtley; Joris Hemelaar
Journal:  EClinicalMedicine       Date:  2022-04-06

3.  Use of antiretroviral therapy in pregnancy and association with birth outcome among women living with HIV in Denmark: A nationwide, population-based cohort study.

Authors:  Ellen Moseholm; Terese Lea Katzenstein; Gitte Pedersen; Isik Somuncu Johansen; Lisa Skyggelund Wienecke; Merete Storgaard; Niels Obel; Nina Weis
Journal:  HIV Med       Date:  2022-04-06       Impact factor: 3.094

4.  Sex-specific increase in susceptibility to metabolic syndrome in adult offspring after prenatal ethanol exposure with post-weaning high-fat diet.

Authors:  Zheng He; Jing Li; Hanwen Luo; Li Zhang; Lu Ma; Liaobin Chen; Hui Wang
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

5.  Effects of HIV infection on maternal and neonatal health in southern Mozambique: A prospective cohort study after a decade of antiretroviral drugs roll out.

Authors:  Raquel González; María Rupérez; Esperança Sevene; Anifa Vala; Sónia Maculuve; Helder Bulo; Arsénio Nhacolo; Alfredo Mayor; John J Aponte; Eusébio Macete; Clara Menendez
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.